サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701870

組み換えタンパク質市場レポート：製品別、用途別、エンドユーザー別、地域別、2025年～2033年

Recombinant Protein Market Report by Product, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 146 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
組み換えタンパク質市場レポート：製品別、用途別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

組み換えタンパク質市場の世界市場規模は2024年に21億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに50億米ドルに達し、2025年から2033年の間に9.55%の成長率（CAGR）を示すと予測しています。

組み換えタンパク質とは、組換えDNAによってコードされた、改変または変化した蛋白質を指します。組換えDNA分子は、標的タンパク質の遺伝子がクローン化されたプラスミドから構成されます。これは、分子クローニングかポリメラーゼ連鎖反応（PCR）によって産生されます。一般的な産物には、キナーゼタンパク質、ヒトインスリン、構造タンパク質、接着分子および受容体、免疫応答タンパク質などがあります。組み換えタンパク質は、主に慢性疾患や希少疾患の新規治療法の開発に利用されています。多くのバイオ製薬会社、学術研究機関、受託研究機関などで広く採用されています。

組み換えタンパク質市場動向：

いくつかの慢性疾患の有病率の上昇と新規治療オプションに対する需要の増加が、世界の組み換えタンパク質市場を牽引しています。これに加えて、タンパク質工学分野への投資の増加や、タンパク質をベースとした医薬品開発への注目の高まりが、市場の成長をさらに増大させています。さらに、多くの政府機関がプロテオミクスとゲノミクスの先端技術導入のための研究開発活動に資金を提供しており、組み換えタンパク質の世界市場に大きな影響を与えています。これに加えて、組み換えタンパク質発現技術の出現は、免疫療法手順で広く使用される高品質の自己抗原の開発につながりました。さらに、創薬分野におけるバイオマーカーの正確な測定のために組み換えタンパク質への要求が高まっていることも、世界市場に明るい展望をもたらしています。これとは別に、組み換えタンパク質のタンパク質分解を減少させたり、グリコシル化の部分的または全体的な喪失を防止するためのバイオファーミングのための最新の分子生物学的アプローチの浸透の高まりは、予測期間にわたって世界の組み換えタンパク質市場を強化すると予想されます。

本レポートで扱う主な質問

  • 2024年の世界の組み換えタンパク質市場の市場規模は？
  • 2025-2033年における世界の組み換えタンパク質の市場成長率は？
  • 世界の組み換えタンパク質市場を牽引する主要因は何か？
  • 世界の組み換えタンパク質市場に対するCOVID-19の影響は？
  • 世界の組み換えタンパク質市場の用途別内訳は？
  • 世界の組み換えタンパク質市場のエンドユーザー別内訳は？
  • 世界の組み換えタンパク質市場における主要地域は？
  • 世界の組み換えタンパク質市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の組み換えタンパク質市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 抗体
  • ホルモン
  • 成長因子
  • サイトカイン
  • その他

第7章 市場内訳：用途別

  • 医薬品の発見と開発
  • 学術調査
  • バイオテクノロジー調査
  • バイオ医薬品製造
  • その他

第8章 市場内訳：エンドユーザー別

  • 製薬会社およびバイオ医薬品会社
  • バイオテクノロジー企業
  • 学術研究機関
  • 契約調査機関
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abcam plc
    • Amgen Inc.
    • Bio-RAD Laboratories Inc.
    • Bio-Techne Corporation
    • Bps Bioscience Inc.
    • Enzo Biochem Inc.
    • Genscript Biotech Corporation
    • Merck KGaA
    • Novo Nordisk A/S
    • ProSpec-Tany TechnoGene Ltd
    • Sanofi S.A.
    • Thermo Fisher Scientific
図表

List of Figures

  • Figure 1: Global: Recombinant Protein Market: Major Drivers and Challenges
  • Figure 2: Global: Recombinant Protein Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Recombinant Protein Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Recombinant Protein Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Recombinant Protein Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Recombinant Protein Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Recombinant Protein Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Recombinant Protein (Antibodies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Recombinant Protein (Antibodies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Recombinant Protein (Hormones) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Recombinant Protein (Hormones) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Recombinant Protein (Growth Factors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Recombinant Protein (Growth Factors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Recombinant Protein (Cytokines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Recombinant Protein (Cytokines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Recombinant Protein (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Recombinant Protein (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Recombinant Protein (Drug Discovery and Development) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Recombinant Protein (Drug Discovery and Development) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Recombinant Protein (Academic Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Recombinant Protein (Academic Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Recombinant Protein (Biotechnology Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Recombinant Protein (Biotechnology Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Recombinant Protein (Biopharmaceutical Production) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Recombinant Protein (Biopharmaceutical Production) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Recombinant Protein (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Recombinant Protein (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Recombinant Protein (Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Recombinant Protein (Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Recombinant Protein (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Recombinant Protein (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Recombinant Protein (Contract Research Organization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Recombinant Protein (Contract Research Organization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Recombinant Protein (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Recombinant Protein (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: North America: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: North America: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: United States: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: United States: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Canada: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Canada: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Asia-Pacific: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Asia-Pacific: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: China: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: China: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Japan: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Japan: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: India: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: India: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: South Korea: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: South Korea: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Australia: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Australia: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Indonesia: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Indonesia: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Europe: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Europe: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Germany: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Germany: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: France: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: France: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: United Kingdom: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: United Kingdom: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Italy: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Italy: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Spain: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Spain: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Russia: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Russia: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Latin America: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Latin America: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Brazil: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Brazil: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Mexico: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Mexico: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Middle East and Africa: Recombinant Protein Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Middle East and Africa: Recombinant Protein Market: Breakup by Country (in %), 2024
  • Figure 86: Middle East and Africa: Recombinant Protein Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Global: Recombinant Protein Industry: SWOT Analysis
  • Figure 88: Global: Recombinant Protein Industry: Value Chain Analysis
  • Figure 89: Global: Recombinant Protein Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Recombinant Protein Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Recombinant Protein Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Recombinant Protein Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Recombinant Protein Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Recombinant Protein Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Recombinant Protein Market: Competitive Structure
  • Table 7: Global: Recombinant Protein Market: Key Players
目次
Product Code: SR112025A6079

The global recombinant protein market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.55% during 2025-2033.

A recombinant protein refers to a modified or altered protein that is encoded by recombinant DNA. The recombinant DNA molecule consists of a plasmid in which the genes for a target protein are cloned. It is produced either by molecular cloning or polymerase chain reaction (PCR). Some of the common product variants include kinase proteins, human insulin, structural proteins, adhesion molecules and receptors, immune response proteins, etc. Recombinant protein is primarily utilized in the development of novel therapies for chronic and rare diseases. It finds widespread adoption in numerous biopharmaceutical companies, academic and research institutes, contract research organizations, etc.

Recombinant Protein Market Trends:

The elevating prevalence of several chronic diseases along with the increasing demand for novel treatment options is primarily driving the global recombinant protein market. In addition to this, the rising investments in the field of protein engineering and the improving focus on protein-based drug development are further augmenting the market growth. Moreover, numerous government bodies are funding R&D activities for the introduction of advanced techniques in proteomics and genomics, which are significantly impacting the global market for recombinant protein. Besides this, the advent of recombinant protein expression technology has led to the development of high-quality autoantigens that are widely used in immunotherapy procedures. Additionally, the growing requirement for recombinant proteins for accurate measurement of biomarkers in the field of drug discovery is also creating a positive outlook for the global market. Apart from this, the rising penetration of latest molecular biology approaches for biopharming to reduce proteolysis of recombinant proteins or prevent the partial or total loss of glycosylation is expected to bolster the global recombinant protein market over the forecast period.

Key Market Segmentation:

Breakup by Product:

  • Antibodies
  • Hormones
  • Growth Factors
  • Cytokines
  • Others

Breakup by Application:

  • Drug Discovery and Development
  • Academic Research
  • Biotechnology Research
  • Biopharmaceutical Production
  • Others

Breakup by End User:

  • Pharmaceutical and Biopharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organization
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A. and Thermo Fisher Scientific.

Key Questions Answered in This Report

  • 1.What was the size of the global recombinant protein market in 2024?
  • 2.What is the expected growth rate of the global recombinant protein market during 2025-2033?
  • 3.What are the key factors driving the global recombinant protein market?
  • 4.What has been the impact of COVID-19 on the global recombinant protein market?
  • 5.What is the breakup of the global recombinant protein market based on application?
  • 6.What is the breakup of the global recombinant protein market based on the end user?
  • 7.What are the key regions in the global recombinant protein market?
  • 8.Who are the key players/companies in the global recombinant protein market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Recombinant Protein Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hormones
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Growth Factors
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cytokines
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Drug Discovery and Development
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Academic Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biotechnology Research
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Biopharmaceutical Production
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Biopharmaceutical Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic and Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Contract Research Organization
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Techne Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Bps Bioscience Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Enzo Biochem Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Genscript Biotech Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Novo Nordisk A/S
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 ProSpec-Tany TechnoGene Ltd
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis